Evidence map›Paper›PMID 36437881›Full record

ArticleSustainable cities and society2023

Quantitative resilience assessment of the network-level metro rail service's responses to the COVID-19 pandemic.

Zhipeng Zhang, Hao Chai, Zhongjie Guo

Abstract read
In one paragraph

Article in Sustainable cities and society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhipeng ZhangState Key Laboratory of Ocean Engineering, School of Naval Architecture, Ocean and Civil Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Hao ChaiState Key Laboratory of Ocean Engineering, School of Naval Architecture, Ocean and Civil Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Zhongjie GuoState Key Laboratory of Ocean Engineering, School of Naval Architecture, Ocean and Civil Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The metro rail system has proven to be the most efficient high-capacity carriers. During the unprecedented coronavirus disease 2019 (COVID-19) challenge, non-pharmaceutical interventions become a widely adopted strategy to limit physical movements and interactions. For situational awareness and decision support, data-driven analytics about serviceability are invaluable to metro agencies and decision-makers of cities. This paper presents a data-driven analytical framework that quantitatively evaluates COVID-19-caused resilience performance of metro rails. Several characteristics (e.g., vulnerability, robustness, rapidity, and degree to return) of the metro system's responses to the disturbance were identified and modeled with multivariate multiple regression. The applicability and rationality of the resilience evaluation model were validated by the metro transit data of the United States. The preliminary results disclosed that metro rail transit encountered more vulnerability (90.6%) in passenger trips than motorbus and light rail (around 70%). A set of statistical models were employed to disentangle the effect of socio-demographic variables and COVID-19-related factors on the metro transit. The disclosed emerging knowledge of resilience provides an in-depth understanding of mobility trends for the public and time-sensitive decision support for the policy effects, to further improve the service and management of the metro system under the spread of the epidemic.

Indexed as

Metro rail systemPandemicQuantitative assessmentResilienceRidership

Identifiers

PMID36437881
PMCPMC9677561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.